Loading…
Aqueous two-phase extraction as a platform in the biomanufacturing industry: Economical and environmental sustainability
The biotech industry is, nowadays, facing unparalleled challenges due to the enhanced demand for biotechnology-based human therapeutic products, such as monoclonal antibodies (mAbs). This has led companies to improve substantially their upstream processes, with the yield of monoclonals increasing to...
Saved in:
Published in: | Biotechnology advances 2011-11, Vol.29 (6), p.559-567 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c525t-48f35399623ad7a99b4abca3458c92fbc90c6ae4bd8f455f790fb1e90bb4b293 |
---|---|
cites | cdi_FETCH-LOGICAL-c525t-48f35399623ad7a99b4abca3458c92fbc90c6ae4bd8f455f790fb1e90bb4b293 |
container_end_page | 567 |
container_issue | 6 |
container_start_page | 559 |
container_title | Biotechnology advances |
container_volume | 29 |
creator | Rosa, P.A.J. Azevedo, A.M. Sommerfeld, S. Bäcker, W. Aires-Barros, M.R. |
description | The biotech industry is, nowadays, facing unparalleled challenges due to the enhanced demand for biotechnology-based human therapeutic products, such as monoclonal antibodies (mAbs). This has led companies to improve substantially their upstream processes, with the yield of monoclonals increasing to titers never seen before. The downstream processes have, however, been overlooked, leading to a production bottleneck. Although chromatography remains the workhorse of most purification processes, several limitations, such as low capacity, scale-related packing problems, low chemical and proteolytic stability and resins' high cost, have arisen. Aqueous two-phase extraction (ATPE) has been successfully revisited as a valuable alternative for the capture of antibodies. One of the important remaining questions for this technology to be adopted by the biotech industries is, now, how it compares to the currently established platforms in terms of costs and environmental impact. In this report, the economical and environmental sustainability of the aqueous two-phase extraction process is evaluated and compared to the currently established protein A affinity chromatography. Accordingly, the ATPE process was shown to be considerably advantageous in terms of process economics, especially when processing high titer cell culture supernatants. This alternative process is able to purify continuously the same amount of mAbs reducing the annual operating costs from 14.4 to 8.5 million (US$/kg) when cell culture supernatants with mAb titers higher than 2.5g/L are processed. |
doi_str_mv | 10.1016/j.biotechadv.2011.03.006 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_902344460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0734975011000395</els_id><sourcerecordid>902344460</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-48f35399623ad7a99b4abca3458c92fbc90c6ae4bd8f455f790fb1e90bb4b293</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxSMEokvhK4AviFOWsR1nY26lKn-kShwoZ2vi2F2vEnuxnaX77XG0Cz32NNboN_P85lUVobCmQNuPu3XvQjZ6i8NhzYDSNfA1QPusWtFuw2vaSfm8WsGGN7XcCLioXqW0A6ACBH9ZXbDyoG0Hq-rh6vdswpxI_hPq_RaTIeYhR9TZBU8wEST7EbMNcSLOk7w1pEhP6GdbmDk6f1_6w5xyPH4iNzr4MDmNI0E_EOMPLgY_GZ9LJxUIncfejS4fX1cvLI7JvDnXy-ruy83d9bf69sfX79dXt7UWTOS66SwXXMqWcRw2KGXfYK-RN6LTktleS9AtmqYfOtsIYTcSbE-NhL5veib5ZfXhtHYfQ3Gasppc0mYc0S-2lQTGm6Zp4Umyky2XHNhCdidSx5BSNFbto5swHhUFteSjduoxH7Xko4Crkk8ZfXsWmfvJDP8H_wVSgPdnAFM5o43otUuPnGBMsnbx9e7EWQwK72Nhfv0sSi0ACNFwXojPJ8KU6x6ciSppZ7w2g4tGZzUE9_R__wLQz7-D</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>896393020</pqid></control><display><type>article</type><title>Aqueous two-phase extraction as a platform in the biomanufacturing industry: Economical and environmental sustainability</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Rosa, P.A.J. ; Azevedo, A.M. ; Sommerfeld, S. ; Bäcker, W. ; Aires-Barros, M.R.</creator><creatorcontrib>Rosa, P.A.J. ; Azevedo, A.M. ; Sommerfeld, S. ; Bäcker, W. ; Aires-Barros, M.R.</creatorcontrib><description>The biotech industry is, nowadays, facing unparalleled challenges due to the enhanced demand for biotechnology-based human therapeutic products, such as monoclonal antibodies (mAbs). This has led companies to improve substantially their upstream processes, with the yield of monoclonals increasing to titers never seen before. The downstream processes have, however, been overlooked, leading to a production bottleneck. Although chromatography remains the workhorse of most purification processes, several limitations, such as low capacity, scale-related packing problems, low chemical and proteolytic stability and resins' high cost, have arisen. Aqueous two-phase extraction (ATPE) has been successfully revisited as a valuable alternative for the capture of antibodies. One of the important remaining questions for this technology to be adopted by the biotech industries is, now, how it compares to the currently established platforms in terms of costs and environmental impact. In this report, the economical and environmental sustainability of the aqueous two-phase extraction process is evaluated and compared to the currently established protein A affinity chromatography. Accordingly, the ATPE process was shown to be considerably advantageous in terms of process economics, especially when processing high titer cell culture supernatants. This alternative process is able to purify continuously the same amount of mAbs reducing the annual operating costs from 14.4 to 8.5 million (US$/kg) when cell culture supernatants with mAb titers higher than 2.5g/L are processed.</description><identifier>ISSN: 0734-9750</identifier><identifier>EISSN: 1873-1899</identifier><identifier>DOI: 10.1016/j.biotechadv.2011.03.006</identifier><identifier>PMID: 21501680</identifier><identifier>CODEN: BIADDD</identifier><language>eng</language><publisher>Kidlington: Elsevier Inc</publisher><subject>affinity chromatography ; Aqueous two-phase systems ; Biological and medical sciences ; Biotechnology ; Biotechnology - economics ; Biotechnology - methods ; business enterprises ; cell culture ; Chromatography, Affinity ; Drug Industry - economics ; Drug Industry - methods ; Economical analysis ; Environment ; environmental impact ; Environmental sustainability ; Fundamental and applied biological sciences. Psychology ; Green Chemistry Technology ; Humans ; industry ; Liquid-Liquid Extraction - economics ; Liquid-Liquid Extraction - methods ; monoclonal antibodies ; operating costs ; Protein A affinity chromatography ; proteolysis ; purification methods ; Purification of antibodies ; resins</subject><ispartof>Biotechnology advances, 2011-11, Vol.29 (6), p.559-567</ispartof><rights>2011 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c525t-48f35399623ad7a99b4abca3458c92fbc90c6ae4bd8f455f790fb1e90bb4b293</citedby><cites>FETCH-LOGICAL-c525t-48f35399623ad7a99b4abca3458c92fbc90c6ae4bd8f455f790fb1e90bb4b293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=25229269$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21501680$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rosa, P.A.J.</creatorcontrib><creatorcontrib>Azevedo, A.M.</creatorcontrib><creatorcontrib>Sommerfeld, S.</creatorcontrib><creatorcontrib>Bäcker, W.</creatorcontrib><creatorcontrib>Aires-Barros, M.R.</creatorcontrib><title>Aqueous two-phase extraction as a platform in the biomanufacturing industry: Economical and environmental sustainability</title><title>Biotechnology advances</title><addtitle>Biotechnol Adv</addtitle><description>The biotech industry is, nowadays, facing unparalleled challenges due to the enhanced demand for biotechnology-based human therapeutic products, such as monoclonal antibodies (mAbs). This has led companies to improve substantially their upstream processes, with the yield of monoclonals increasing to titers never seen before. The downstream processes have, however, been overlooked, leading to a production bottleneck. Although chromatography remains the workhorse of most purification processes, several limitations, such as low capacity, scale-related packing problems, low chemical and proteolytic stability and resins' high cost, have arisen. Aqueous two-phase extraction (ATPE) has been successfully revisited as a valuable alternative for the capture of antibodies. One of the important remaining questions for this technology to be adopted by the biotech industries is, now, how it compares to the currently established platforms in terms of costs and environmental impact. In this report, the economical and environmental sustainability of the aqueous two-phase extraction process is evaluated and compared to the currently established protein A affinity chromatography. Accordingly, the ATPE process was shown to be considerably advantageous in terms of process economics, especially when processing high titer cell culture supernatants. This alternative process is able to purify continuously the same amount of mAbs reducing the annual operating costs from 14.4 to 8.5 million (US$/kg) when cell culture supernatants with mAb titers higher than 2.5g/L are processed.</description><subject>affinity chromatography</subject><subject>Aqueous two-phase systems</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Biotechnology - economics</subject><subject>Biotechnology - methods</subject><subject>business enterprises</subject><subject>cell culture</subject><subject>Chromatography, Affinity</subject><subject>Drug Industry - economics</subject><subject>Drug Industry - methods</subject><subject>Economical analysis</subject><subject>Environment</subject><subject>environmental impact</subject><subject>Environmental sustainability</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Green Chemistry Technology</subject><subject>Humans</subject><subject>industry</subject><subject>Liquid-Liquid Extraction - economics</subject><subject>Liquid-Liquid Extraction - methods</subject><subject>monoclonal antibodies</subject><subject>operating costs</subject><subject>Protein A affinity chromatography</subject><subject>proteolysis</subject><subject>purification methods</subject><subject>Purification of antibodies</subject><subject>resins</subject><issn>0734-9750</issn><issn>1873-1899</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkU9v1DAQxSMEokvhK4AviFOWsR1nY26lKn-kShwoZ2vi2F2vEnuxnaX77XG0Cz32NNboN_P85lUVobCmQNuPu3XvQjZ6i8NhzYDSNfA1QPusWtFuw2vaSfm8WsGGN7XcCLioXqW0A6ACBH9ZXbDyoG0Hq-rh6vdswpxI_hPq_RaTIeYhR9TZBU8wEST7EbMNcSLOk7w1pEhP6GdbmDk6f1_6w5xyPH4iNzr4MDmNI0E_EOMPLgY_GZ9LJxUIncfejS4fX1cvLI7JvDnXy-ruy83d9bf69sfX79dXt7UWTOS66SwXXMqWcRw2KGXfYK-RN6LTktleS9AtmqYfOtsIYTcSbE-NhL5veib5ZfXhtHYfQ3Gasppc0mYc0S-2lQTGm6Zp4Umyky2XHNhCdidSx5BSNFbto5swHhUFteSjduoxH7Xko4Crkk8ZfXsWmfvJDP8H_wVSgPdnAFM5o43otUuPnGBMsnbx9e7EWQwK72Nhfv0sSi0ACNFwXojPJ8KU6x6ciSppZ7w2g4tGZzUE9_R__wLQz7-D</recordid><startdate>20111101</startdate><enddate>20111101</enddate><creator>Rosa, P.A.J.</creator><creator>Azevedo, A.M.</creator><creator>Sommerfeld, S.</creator><creator>Bäcker, W.</creator><creator>Aires-Barros, M.R.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>7ST</scope><scope>7U6</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20111101</creationdate><title>Aqueous two-phase extraction as a platform in the biomanufacturing industry: Economical and environmental sustainability</title><author>Rosa, P.A.J. ; Azevedo, A.M. ; Sommerfeld, S. ; Bäcker, W. ; Aires-Barros, M.R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-48f35399623ad7a99b4abca3458c92fbc90c6ae4bd8f455f790fb1e90bb4b293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>affinity chromatography</topic><topic>Aqueous two-phase systems</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Biotechnology - economics</topic><topic>Biotechnology - methods</topic><topic>business enterprises</topic><topic>cell culture</topic><topic>Chromatography, Affinity</topic><topic>Drug Industry - economics</topic><topic>Drug Industry - methods</topic><topic>Economical analysis</topic><topic>Environment</topic><topic>environmental impact</topic><topic>Environmental sustainability</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Green Chemistry Technology</topic><topic>Humans</topic><topic>industry</topic><topic>Liquid-Liquid Extraction - economics</topic><topic>Liquid-Liquid Extraction - methods</topic><topic>monoclonal antibodies</topic><topic>operating costs</topic><topic>Protein A affinity chromatography</topic><topic>proteolysis</topic><topic>purification methods</topic><topic>Purification of antibodies</topic><topic>resins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rosa, P.A.J.</creatorcontrib><creatorcontrib>Azevedo, A.M.</creatorcontrib><creatorcontrib>Sommerfeld, S.</creatorcontrib><creatorcontrib>Bäcker, W.</creatorcontrib><creatorcontrib>Aires-Barros, M.R.</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Environment Abstracts</collection><collection>Sustainability Science Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Biotechnology advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rosa, P.A.J.</au><au>Azevedo, A.M.</au><au>Sommerfeld, S.</au><au>Bäcker, W.</au><au>Aires-Barros, M.R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aqueous two-phase extraction as a platform in the biomanufacturing industry: Economical and environmental sustainability</atitle><jtitle>Biotechnology advances</jtitle><addtitle>Biotechnol Adv</addtitle><date>2011-11-01</date><risdate>2011</risdate><volume>29</volume><issue>6</issue><spage>559</spage><epage>567</epage><pages>559-567</pages><issn>0734-9750</issn><eissn>1873-1899</eissn><coden>BIADDD</coden><abstract>The biotech industry is, nowadays, facing unparalleled challenges due to the enhanced demand for biotechnology-based human therapeutic products, such as monoclonal antibodies (mAbs). This has led companies to improve substantially their upstream processes, with the yield of monoclonals increasing to titers never seen before. The downstream processes have, however, been overlooked, leading to a production bottleneck. Although chromatography remains the workhorse of most purification processes, several limitations, such as low capacity, scale-related packing problems, low chemical and proteolytic stability and resins' high cost, have arisen. Aqueous two-phase extraction (ATPE) has been successfully revisited as a valuable alternative for the capture of antibodies. One of the important remaining questions for this technology to be adopted by the biotech industries is, now, how it compares to the currently established platforms in terms of costs and environmental impact. In this report, the economical and environmental sustainability of the aqueous two-phase extraction process is evaluated and compared to the currently established protein A affinity chromatography. Accordingly, the ATPE process was shown to be considerably advantageous in terms of process economics, especially when processing high titer cell culture supernatants. This alternative process is able to purify continuously the same amount of mAbs reducing the annual operating costs from 14.4 to 8.5 million (US$/kg) when cell culture supernatants with mAb titers higher than 2.5g/L are processed.</abstract><cop>Kidlington</cop><pub>Elsevier Inc</pub><pmid>21501680</pmid><doi>10.1016/j.biotechadv.2011.03.006</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0734-9750 |
ispartof | Biotechnology advances, 2011-11, Vol.29 (6), p.559-567 |
issn | 0734-9750 1873-1899 |
language | eng |
recordid | cdi_proquest_miscellaneous_902344460 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | affinity chromatography Aqueous two-phase systems Biological and medical sciences Biotechnology Biotechnology - economics Biotechnology - methods business enterprises cell culture Chromatography, Affinity Drug Industry - economics Drug Industry - methods Economical analysis Environment environmental impact Environmental sustainability Fundamental and applied biological sciences. Psychology Green Chemistry Technology Humans industry Liquid-Liquid Extraction - economics Liquid-Liquid Extraction - methods monoclonal antibodies operating costs Protein A affinity chromatography proteolysis purification methods Purification of antibodies resins |
title | Aqueous two-phase extraction as a platform in the biomanufacturing industry: Economical and environmental sustainability |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A05%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aqueous%20two-phase%20extraction%20as%20a%20platform%20in%20the%20biomanufacturing%20industry:%20Economical%20and%20environmental%20sustainability&rft.jtitle=Biotechnology%20advances&rft.au=Rosa,%20P.A.J.&rft.date=2011-11-01&rft.volume=29&rft.issue=6&rft.spage=559&rft.epage=567&rft.pages=559-567&rft.issn=0734-9750&rft.eissn=1873-1899&rft.coden=BIADDD&rft_id=info:doi/10.1016/j.biotechadv.2011.03.006&rft_dat=%3Cproquest_cross%3E902344460%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c525t-48f35399623ad7a99b4abca3458c92fbc90c6ae4bd8f455f790fb1e90bb4b293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=896393020&rft_id=info:pmid/21501680&rfr_iscdi=true |